Source: Kalkine Media

Midas Pharma: Zoono Group's Share Surge Over 40% Post Agreement With Midas Pharma Announcement

Zoono Group Limited (ASX: ZNO) today announced that it has entered into an agreement with Midas Pharma GmbH in Ingelheim, Germany. The agreement aims to bring both parties together for sales and distribution in the EU and selected global markets. Midas Pharma is a globally reputed pharmaceutical company with robust sales and distribution channels across [...]The post Zoono Group's Share Surge Over 40% Post Agreement With Midas Pharma Announcement appeared first on Kalkine Media.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Karl-Heinz Schleicher's photo - President & CEO of Midas Pharma

President & CEO

Karl-Heinz Schleicher

CEO Approval Rating

- -/100

Read more